The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study
暂无分享,去创建一个
[1] L. Curtis,et al. Unit Costs of Health and Social Care 2016 , 2015 .
[2] L. Lindholm,et al. Atenolol in hypertension: is it a wise choice? , 2004, The Lancet.
[3] J F Potter,et al. Extract from : , 2009 .
[4] N J Wald,et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[5] N J Wald,et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.
[6] Muhammad Mamdani,et al. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.
[7] M. Weinstein,et al. Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.
[8] C. Mulrow,et al. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.
[9] U. P. S. T. Force,et al. Measuring Quality: Are We Ready To Compare the Quality of Care among Physician Groups? , 2002, Annals of Internal Medicine.
[10] M. Roncaglioni. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice , 2001, The Lancet.
[11] J. Caro,et al. Persistence with treatment for hypertension in actual practice. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[12] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[13] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[14] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[15] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[16] Nina Singh,et al. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.
[17] M. Bayes,et al. The Probability of , 2001 .
[18] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[19] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.